AMLX · Categories · Form 3

AMLX - SEC Form 3 initial insider statements

Amylyx Pharmaceuticals Inc. (AMLX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for AMLX

• 772d
  SEC Form 3 filed by new insider Zeiher Bernhardt G

  3 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 879d
  SEC Form 3 filed by new insider Bedrosian Camille L

  3 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 1096d
  SEC Form 3 filed by new insider Frates James M (Amendment)

  3/A - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 1133d
  SEC Form 3 filed by new insider Firestone Karen

  3 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 1501d
  SEC Form 3 filed by new insider Morningside Venture Investments Ltd (Amendment)

  3/A - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 1518d
  SEC Form 3 filed by new insider Mazzariello Gina

  3 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 1552d
  SEC Form 3 filed by new insider Morningside Venture Investments Ltd

  3 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)
• 1556d
  SEC Form 3: New insider Dragsa 96 Llc claimed ownership of 2,300,000 shares

  3 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

Other AMLX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends